Nikitin O. D., Rasputnyak S. S.
QUALITY OF LIFE AND LEVEL OF ANXIETY IN PATIENTS WITH CHRONIC CYSTITIS BEFORE AND AFTER MENOPAUSE
Show/Download
About the author:
Nikitin O. D., Rasputnyak S. S.
Heading:
CLINICAL AND EXPERIMENTAL MEDICINE
Type of article:
Scientific article
Annotation:
Chronic cystitis is a common condition in urological practice, characterised by a wide range of clinical manifes tations that persist over a prolonged period, adversely affecting patients’ overall well-being and quality of life. The persistence of symptoms often leads to the development of anxiety disorders in women of various age groups, which in turn contributes to the intensification of pain syndrome and dysuric symptoms. The aim of the study was to assess the quality of life and anxiety levels in patients with chronic cystitis across different age groups and to conduct a comparative analysis in relation to socio-demographic characteristics and the severity of pain symptoms. The study included 165 patients, from whom control and main groups were formed. Based on menopausal status, the main group was further divided into subgroups Ia (premenopausal women) and Ib (postmenopausal women). Quality of life, anxiety levels, and the severity of pelvic pain symptoms were evaluated. The results were subjected to statistical analysis. It was found that the overall quality of life in women with chronic cystitis, both pre- and postmenopausal, was significantly lower than in the control group. A comprehensive evaluation of pelvic pain was associated with lower scores on the physical functioning, pain intensity, vitality, and mental health scales. Regarding anxiety, results in the main group, regardless of age, were statistically higher than those in the control group. The data obtained in dicate a marked impact of chronic cystitis on quality of life and anxiety levels among women of different age groups. The observed correlations between disease duration, the presence of a sexual partner, and patients’ psycho-emotion al state suggest the need for further research into the complex interplay between somatic and psychogenic factors.
Tags:
Bibliography:
- Daniels AM, Schulte AR, Herndon CM. Interstitial Cystitis: An Update on the Disease Process and Treatment. J Pain Palliat Care Pharmacother. 2018;32(1):49-58. DOI: 10.1080/15360288.2018.1476433.
- Dellis AE, Kostakopoulos N, Papatsoris AG. Is there an effective therapy of interstitial cystitis/bladder pain syndrome? Expert Opin Pharmacother. 2019;20(12):1417-9. DOI: 10.1080/14656566.2019.1615056.
- Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28(10):2641-50. DOI: 10.1007/s11136-019-02214-9.
- Uysal M, Sirgy MJ. Quality-of-life indicators as performance measures. Ann Tourism Res. 2019;76:291-300. DOI: 10.1016/j. annals.2018.12.016.
- Michalos AC, editor. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht: Springer; 2014. Chapter, World Health Organization Quality of Life (WHOQOL) Assessment; p. 7260-7261. DOI: 10.1007/978-94-007-0753-5_3282.
- Cunningham AR, Gu L, Dubinskaya A, De Hoedt AM, Barbour KE, Kim J, et al. Quality-of-life impact of interstitial cystitis and other pelvic pain syndromes. Front Pain Res (Lausanne). 2023;4:1149783. DOI: 10.3389/fpain.2023.1149783.
- Volpe KA, Mandelbaum R, Rodriguez LV, Özel BZ, Rolston R, Dancz CE. Does Obtaining a Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome Improve Symptoms or Quality of Life? A Cross-sectional Questionnaire-Based Study. Female Pelvic Med Reconstr Surg. 2021;27(5):328-33. DOI: 10.1097/SPV.0000000000000840.
- Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care Res (Hoboken). 2011;63(11):383-412. DOI: 10.1002/acr.20541.
- Kharchenko DM. Psykhosomatychni rozlady. Teorii, metody diahnostyky, rezultaty doslidzhen. Kyiv: Slovo; 2015. 278 s. [in Ukrainian].
- Rafi B, Nassir A, Baazeem A, Almalki AA, Mandourah F. Arabic translation and validation of Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale. Bull Natl Res Cent. 2022;46:251. DOI: 10.1186/s42269-022-00942-6.
- Mitchell G, McCambridge J. Interactions Between the U.S. National Institute on Alcohol Abuse and Alcoholism and the Alcohol Industry: Evidence From Email Correspondence 2013-2020. J Stud Alcohol Drugs. 2023;84(1):11-26. DOI: 10.15288/jsad.22-00184.
- Vasudevan V, Moldwin R. Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome. Asian J Urol. 2017;4(1):50-4. DOI: 10.1016/j.ajur.2016.08.014.
- Crawford A, Tripp DA, Nickel JC, Carr L, Moldwin R, Katz L, et al. Depression and helplessness impact interstitial cystitis/bladder pain syndrome pain over time. Can Urol Assoc J. 2019;13(10):328-33. DOI: 10.5489/cuaj.5703.
- Cepeda MS, Reps J, Sena AG, Ochs-Ross R. Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression. Int Neurourol J. 2019;23(1):40-5. DOI: 10.5213/inj.1836182.091.
- Mahjani B, Koskela LR, Batuure A, Gustavsson Mahjani C, Janecka M, Hultman CM, et al. Systematic review and meta-analysis identify significant relationships between clinical anxiety and lower urinary tract symptoms. Brain Behav. 2021;11(9):e2268. DOI: 10.1002/brb3.2268.
- Yu WR, Peng TC, Yeh HL, Kuo HC. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome. Neurourol Urodyn. 2019;38(6):1602-10. DOI: 10.1002/nau. 24019.
Publication of the article:
«Bulletin of problems biology and medicine», Issue 2,177, 233-243 pages, index UDC 618.17-008.1-02
